Washington Report Articles
The U.S. Department of Health and Human Services has doubled funding for its Childhood Cancer Data Initiative at the National Institutes of Health
The National Institutes of Health launched the $50 Million Autism Data Science Initiative, supporting 13 pioneering projects
The National Institutes of Health granted Scott Pegan, PhD, nearly $3.4 million to lead an study to develop protective antibodies against Crimean Congo hemorrhagic fever virus
The National Institutes of Health announced a significant change to the terms and conditions governing federal funding applicable to all NIH grants, cooperative agreements and other awards, including future awards.
The U.S. Food and Drug Administration is requiring safety labeling changes to all opioid pain medications to better emphasize and explain the risks associated with their long-term use.
The U.S. Department of Health and Human Services (HHS) has begun a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA).
Autism prevalence in the U.S. has increased from one in 36 children to one in 31, according to the Centers for Disease Control and Prevention’s (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey.
The University of Toledo will receive $473,632 from the National Institute of Dental and Craniofacial Research to explore how the body’s immune system responds to the condition known as oral thrush.
A draft budget proposal circulating among federal officials suggests a cut in the U.S. Department of Health and Human Services’ discretionary spending by as much as one-third, or tens of billions of dollars.
The U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) have announced the development of the next-generation, universal vaccine platform, Generation Gold Standard, using a beta-propiolactone (BPL)-inactivated, whole-virus platform.
The Centers for Medicare and Medicaid Services released the 2026 Advance Notice for the Medicare Advantage and the Medicare Part D Prescription Drug Programs that would update payment policies for these programs.